Type of antibody:
Primary antibodies, Recombinant antibodies
recombinant human IgG1
Alternative names:

Specifications for E4BP4 (NFIL3) Antibody, anti-human, REAfinity™


Clone REA732 recognizes the human E4BP4 (NFIL3) antigen, a basic leucine zipper transcription factor that is regulated by the cytokine IL-3. E4BP4 is highly expressed in lung and in lower levels in brain and spinal cord. E4BP4 acts with members of the PAR family of transcription factors with which it shares DNA-binding specificity. It plays a role in commitment to cell survival versus apoptosis, anti-inflammatory response, and transcriptional controlling of the mammalian circadian clock. Furthermore, E4BP4 plays an essential role in the development of CD8α
conventional dendritic cells (cDCs).
Additional information: Clone REA732 displays negligible binding to Fc receptors.

Alternative names


Detailed product information

Technical specifications

Isotyperecombinant human IgG1
Isotype controlREA Control Antibody (I), human IgG1
Hosthuman cell line
Type of antibodyPrimary antibodies, Recombinant antibodies
AntigenE4BP4 (NFIL3)
Alternative names of antigenNFIL3
Molecular mass of antigen [kDa]52
Distribution of antigenother, bladder, bone marrow, lymph node, muscle, testicle, trachea
Entrez Gene ID4783
RRIDAB_2651592, AB_2651593, AB_2651594, AB_2651591

Resources for E4BP4 (NFIL3) Antibody, anti-human, REAfinity™


Please follow this
to search for Certificates of Analysis (CoA) by lot number.

References for E4BP4 (NFIL3) Antibody, anti-human, REAfinity™


  1. Kashiwada, M. et al. (2011) NFIL3/E4BP4 is a key transcription factor for CD8α⁺ dendritic cell development. Blood 117(23): 6193-6197
  2. Cowell, I. G. (2002) E4BP4/NFIL3, a PAR-related bZIP factor with many roles. Bioessays 24(11): 1023-1029
  3. Hulme, D. J. et al. (2000) Exclusion of NFIL3 as the gene causing hereditary sensory neuropathy type I by mutation analysis. Hum. Genet. 106(6): 594-596

Related products for
E4BP4 (NFIL3) Antibody, anti-human, REAfinity™

3 products available

Seems like you are coming from USA!
Do you want to visit our website in your country?